SMARTER INVESTMENT IN THE RESEARCH LONG GAME Government support for health and medical researchers and innovators needing investment cycle review
With
Nadia Levin, CEO
Research Australia
OP-ED SEGMENT
Filmed in Sydney | April 2026
In this Op-Ed, Nadia Levin, CEO of Research Australia, spoke with the Australian Health Journal about the need for smarter and more strategic investment in Australia’s health and medical research sector.
Levin argued that Australia’s approach to health and medical research has been shaped too heavily by short-term political cycles rather than a long-term national vision. She emphasised that meaningful progress in science, innovation, and healthcare requires sustained investment over many years.
According to Levin, health and medical research should not be viewed simply as a social good, but as a major driver of economic growth, productivity, and national resilience. She highlighted that every preventable hospital admission, faster diagnosis, or locally developed medical product contributes to economic performance.
Research Australia estimates that for every dollar invested in health and medical research, the Australian economy receives around four dollars in return.
Levin pointed to Australia’s past achievements, including the development of IVF, the cochlear implant, the HPV vaccine, and ultrasound imaging, as examples of how research can improve lives while creating industries and export opportunities.
A major focus in the need to strengthen the entire research pipeline, from early-stage discovery through to clinical translation, commercialisation, and integration into healthcare systems. Research Australia in a media release March 2026, noted that while the Medical Research Future Fund was created to distribute around $1 billion annually, it is currently providing only about $650 million each year despite holding approximately $24.5 billion.
Levin referenced costings from the Parliamentary Budget Office (PBO), commissioned by Dr Monique Ryan MP, showing the fund could distribute up to $1.4 billion annually without reducing its capital base, arguing that the money, demand, and need already exist, but stronger government commitment is required.
Source: Adapted from Research Australia media release March 2026
-
New AIDH digital strategy adds pillar to previous aims
Australasian Institute of Digital Health (AIDH), today has released the AIDH Strategic Plan for 2026–2028, recently approved by the Board. This plan acts as a roadmap, as well as a shared statement of purpose and intent, guiding where AIDH will focus its effort, investment and voice over the next three years.
-
Elevating Professional Standards in the Medtech and Pharmaceutical Sector
ARCS Australia Ltd, the peak body representing professionals in the MedTech and Pharmaceutical sector, this week announced a series of significant changes at its annual conference.
Dr Tim Boyle, CEO of ARCS Australia Ltd speaking to Australian Health Journal says, “These initiatives are central to strategy to build professionalism within the sector, increase capability and enhance the professional standing of its members.”
-
Sonia Marshall – South Western Sydney Local Health District
South Western Sydney Local Health District serves nearly 1 million people in a rapidly growing area of Sydney. Currently 250-300 families a week are moving into the region and with a growing population, the health district requires well executed strategy and delivery of healthcare to the population. Executive Director Sonia Marshall spoke with Australian Health Journal reporter Anne Dao at last week’s Australian Healthcare Week in Sydney, on supporting staff and the community. Sonia highlights the mission of delivering Safe Quality Healthcare at all times. In-time patient feedback is important and the SWSLHD has implemented a system called “My Experience Matters” to give near immediate response from patients on their level of care, whilst they are still on site at the hospital. The aim of the initiative is to quickly identify bad experiences that could be rectified.
